Molecular Partners AG (SWX:MOLN)
Switzerland · Delayed Price · Currency is CHF 3.010
-0.130 (-4.14%)
May 13, 2026, 5:31 PM CET
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of 117.47 million as of May 13, 2026. Its market cap has decreased by -6.03% in one year.
Market Cap
117.47M
Enterprise Value
42.05M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.01
Market Cap Chart
Since November 4, 2014, Molecular Partners AG's market cap has decreased from 426.07M to 117.47M, a decrease of -72.43%. That is a compound annual growth rate of -10.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 117.47M | -7.21% |
| Dec 30, 2025 | 126.60M | -15.41% |
| Dec 30, 2024 | 149.66M | 32.42% |
| Dec 29, 2023 | 113.02M | -43.62% |
| Dec 30, 2022 | 200.48M | -65.16% |
| Dec 30, 2021 | 575.43M | -4.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.79B |
| Idorsia | 1.09B |
| Basilea Pharmaceutica AG | 684.64M |
| Newron Pharmaceuticals | 283.01M |
| Santhera Pharmaceuticals Holding AG | 241.29M |
| BioVersys AG | 157.31M |
| Xlife Sciences AG | 118.81M |
| MindMaze Therapeutics Holding | 56.92M |